Highline Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.6K Buy
511
+55
+12% +$4.98K 0.01% 276
2026
Q2
$41.8K Buy
456
+23
+5% +$2.01K 0.01% 256
2026
Q1
$36.9K Buy
433
+38
+10% +$3.39K 0.01% 204
2025
Q4
$31.2K Buy
395
+95
+32% +$7.45K 0.01% 183
2025
Q3
$24K Buy
300
+198
+194% +$16.9K 0.01% 244
2025
Q2
$9.28K Buy
102
+55
+117% +$5.02K ﹤0.01% 344
2025
Q1
$4.41K Buy
47
+25
+114% +$2.24K ﹤0.01% 455
2024
Q4
$2K Sell
22
-9
-29% -$859 ﹤0.01% 458
2024
Q3
$3.22K Buy
31
+9
+41% +$917 ﹤0.01% 400
2024
Q2
$2.14K Buy
22
+6
+38% +$553 ﹤0.01% 386
2024
Q1
$1.44K Hold
16
– – ﹤0.01% 347
2023
Q4
$1.28K Hold
16
– – ﹤0.01% 326
2023
Q3
$1.14K Hold
16
– – ﹤0.01% 305
2023
Q2
$1.23K Hold
16
– – ﹤0.01% 256
2023
Q1
$1.2K Sell
16
-4
-20% -$297 ﹤0.01% 257
2022
Q4
$1.58K Buy
20
+4
+25% +$300 ﹤0.01% 236
2022
Q3
$1.12K Buy
+16
New +$1.26K ﹤0.01% 252

Other funds holding CL

Highline Wealth Partners's CL Position: Q3 2026 in Review

Highline Wealth Partners increased its Colgate-Palmolive (CL) stake by 12% in Q3 2026, buying an estimated $4.98K and bringing the position to 511 shares worth $43.6K. The position accounts for 0.01% of the portfolio, ranked #276.

Highline Wealth Partners first reported a position in CL in Q3 2022 and has held it in 17 quarters since. 1,958 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Highline Wealth Partners held 511 shares of Colgate-Palmolive worth $43.6K as of Q3 2026.
  • Highline Wealth Partners bought 55 Colgate-Palmolive shares in Q3 2026, an estimated $4.98K.
  • Colgate-Palmolive made up 0.01% of Highline Wealth Partners's portfolio in Q3 2026, its #276 holding.
  • Highline Wealth Partners first reported a position in Colgate-Palmolive in Q3 2022 and has held it in 17 quarters since.
  • 1,958 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Highline Wealth Partners's 13F filing for Q3 2026, filed 19 Oct 2026.